t e c h n i c a l r e p o r t s
The intestine is densely populated by anaerobic commensal bacteria. These microorganisms shape immune system development, but understanding of host-commensal interactions is hampered by a lack of tools for studying the anaerobic intestinal environment. We applied metabolic oligosaccharide engineering and bioorthogonal click chemistry to label various commensal anaerobes, including Bacteroides fragilis, a common and immunologically important commensal. We studied the dissemination of B. fragilis after acute peritonitis and characterized the interactions of the intact microbe and its polysaccharide components in myeloid and B cell lineages. We were able to assess the distribution and colonization of labeled B. fragilis along the intestine, as well as niche competition after coadministration of multiple species of the microbiota. We also fluorescently labeled nine additional commensals (eight anaerobic and one microaerophilic) from three phyla common in the gut-Bacteroidetes, Firmicutes and Proteobacteria-as well as one aerobic pathogen (Staphylococcus aureus). This strategy permits visualization of the anaerobic microbial niche by various methods, including intravital two-photon microscopy and non-invasive whole-body imaging, and can be used to study microbial colonization and host-microbe interactions in real time.
The human gastrointestinal tract is densely populated by >10 13 bacteria of various species, which have evolved to have important roles in human health and disease [1] [2] [3] [4] [5] [6] . Despite the many benefits of the microbiota [6] [7] [8] [9] , its dysregulation can cause diseases such as inflammatory bowel disease 10 and autoimmune disease 11 . Although research with germ-free 12 (GF) mice established critical roles for the microbiota as a whole, the contribution of individual bacterial species and their molecular components has been more difficult to determine. Although certainly worthwhile, the development of tools that permit a selected species to be labeled, followed and studied in the context of a diverse microbiota is challenging.
Bacterium-derived polysaccharides and glycoproteins provide modes of communication that are pivotal in bacterial-host cross-talk 13 . To study these components, we chose B. fragilis, a Gramnegative obligate anaerobe and common gut commensal that affects the host immune system via glycans 14 . B. fragilis produces eight capsular polysaccharides (A-H) and many glycoproteins 15 , and its colonization depends on the presence of at least one polysaccharide 16 . Polysaccharide A (PSA) exerts immunomodulation through actions such as correcting imbalances in type 1 and 2 helper T cells, inducing regulatory T cells and generating protective interleukin 10 (IL-10) responses in models of colitis and experimental autoimmune encephalomyelitis 14, 17, 18 . The mechanisms underlying immunoprotection remain uncharacterized, including which immune cells interact with live organisms, how bacterial polysaccharides are shed and where in the intestine they are presented to the immune system. Although fluorescent PSA has been used previously 14 , it has not provided a physiological view of a live symbiont's interaction with the host. Addressing these questions in a temporal-spatial manner requires labeling and tracking of B. fragilis and, if possible, its glycan components. Conventional fluorescent labeling is useful but challenging in this context, as fluorescent proteins require aerobic conditions 19, 20 but most gut commensals are anaerobes, and many labeling methods are based on genetic techniques that target proteins, not polysaccharides.
To overcome these limitations, we used metabolic oligosaccharide engineering (MOE) and bioorthogonal click chemistry (BCC) 21 to label and track live B. fragilis and its polysaccharides. Via this method a small functional group is incorporated into biomolecules by a cell's endogenous biosynthetic machinery, and BCC is used to induce rapid reaction of this group with a second chemical group, leading to the formation of a stable covalent bond 22 . This technique has been used successfully in studies of glycoconjugates and polysaccharides in living systems 23 , including in prokaryotic organisms 24, 25 . We aimed to extend its application to in vivo studies of host-commensal interactions in the anaerobic intestine.
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We report that B. fragilis readily incorporated azide-containing nonnatural sugars into its natural carbohydrate structures-specifically, PSA. We labeled and tracked B. fragilis and its capsular polysaccharides in mice in vitro and in vivo after acute peritonitis and in its natural intestinal niche. We found that this method was compatible with advanced imaging technologies, and we applied it to nine additional gut commensals (eight anaerobic and one microaerophilic) from five genera, as well as a common aerobic pathogen, S. aureus. Finally, we used this technique to differentiate and track three anaerobic gut commensal species administered simultaneously, demonstrating its applicability to studies of niche preferences and competition.
RESULTS

Generation of fluorescently labeled B. fragilis by MOE
We incorporated azide functional groups into newly synthesized polysaccharides by supplementing bacterial growth medium with azide-modified sugars (Fig. 1a) . We predicted that B. fragilis would use azide-modified tetraacetylated-N-azidoacetylgalactosamine (GalNAz), as PSA-the most abundant polysaccharide of B. fragiliscomprises repeating units of N-acetyl-galactosamine (GalNAc) 26 . We grew B. fragilis in D-GalNAz-supplemented media and then incubated the bacteria with fluorescent alkyne or dibenzocyclooctyne (DIBO) derivatives via copper-dependent or copper-independent reactions, respectively. Flow cytometry showed higher fluorescence in the copper-dependent labeling reaction (Fig. 1b) . Copper catalysis can be toxic to cells; we found a decrease in viability after copper-dependent labeling (Fig. 1c) . Because our goal was to track live organisms, we incorporated labeling techniques that used copper-independent DIBO derivatives. The use of DIBO derivatives resulted in higher mean fluorescence intensity (MFI) after longer incubation times ( Fig. 1b) with no toxicity (Fig. 1c) . Labeling was specific for GalNAz incorporation, as D-galactose supplementation did not induce fluorescence (Fig. 1d) . Moreover, GalNAz supplementation in regular glucose-rich media yielded bacteria that remained amenable to labeling, which suggests that bacteria can be grown under 'optimal' conditions without a measurable impact from azido-sugar supplementation.
We determined whether other azide-modified glucosamine (GlcNAz), mannosamine (ManNAz) and fucose (FucAz) analogs allowed labeling of B. fragilis. Organisms grown with GlcNAz, ManNAz or FucAz had lower MFIs than those grown with GalNAz ( Fig. 1e) , suggesting that GalNAz is the most efficient azido-sugar for MOE-BCC labeling of B. fragilis, and implying preferential-but not universal-labeling of a unique carbohydrate.
We studied fluorescence dilution during bacterial growth, analogous to the use of carboxyfluorescein succinimidyl ester in proliferating eukaryotic cells 27 . Under optimal growth conditions, fluorescently labeled bacteria gradually lost fluorescence over the first 8 h and reached a plateau at 8-24 h (Fig. 1f) , with a calculated fluorescence half-life during log phase of approximately 1.6 h. Fluorescence loss coincided with increased bacterial counts during log phase, with no measurable growth defects associated with fluorescent labeling (Fig. 1g) .
Surface polysaccharide expression and phase variation are important for B. fragilis colonization 16, 28 . However, the kinetics of carbohydrate shedding, turnover and production are unknown. We performed sequential labeling, whereby B. fragilis was labeled with AF488-DIBO, grown overnight in regular conditions supplemented with additional GalNAz, and then labeled with tetramethylrhodamine (TAMRA)-DIBO. The bacteria incorporated newly synthesized carbohydrates into their polysaccharide-rich glycocalyx layer and in most cases displayed both old (AF488-labeled) and newly synthesized carbohydrates, suggesting that carbohydrate metabolism is not impaired by MOE-BCC (Fig. 1h) .
MOE-BCC labeling targets fluorescence to the glycocalyx Using microscopy ( Fig. 1i) and high-resolution 3D rendering ( Fig. 1j  and Supplementary Video 1) , we demonstrated that fluorescence localized to the outer surface of B. fragilis, consistent with targeting of the polysaccharide-rich glycocalyx. To examine whether fluorescence preferentially targeted PSA, we studied wild-type PSA 29 and two mutant strains: ∆PSA, in which an 8-kb deletion of the PSA locus removes essential PSA synthesis genes 29 , and ∆mpiM44 (ref. 30) , which constitutively synthesizes only PSA (Supplementary Table 1 ). Flow cytometry (Fig. 2a) and confocal microscopy ( Fig. 2b) showed incorporation of Alexa Fluor 647 (AF647)-DIBO fluorescence in both wild-type PSA and ∆mpiM44 but minimal labeling in the ∆PSA strain. Next we stained AF647-labeled ∆mpiM44 and ∆PSA with antibodies specific for PSA or B. fragilis. The AF647 label costained with anti-PSA in ∆mpiM44 but not ∆PSA (Fig. 2c) . Western blotting showed AF647 fluorescence in conjunction with PSA expression in wild-type PSA and ∆mpiM44 but not in ∆PSA (Fig. 2d) . Taken together, these data suggest that GalNAz is incorporated into PSA, the predominant polysaccharide labeled in B. fragilis.
Labeled PSA retains immunomodulatory activity
In MOE-BCC, the fluorescent alkyne preferentially labels PSA. This observation suggests that, in addition to direct visualization of the bacterium, MOE-BCC permits tracking of microbial components, even upon their dissociation from intact bacteria. Neither GalNAz incorporation into PSA (Fig. 2e) nor fluorescent labeling of B. fragilis (Fig. 2f) affected IL-10 production in dendritic cell (DC)-CD4 + T cell coculture assays (compared with production observed with native PSA and unlabeled B. fragilis, respectively), which suggests that MOE-BCC does not ablate PSA's immunomodulatory activity.
Visualization of host-microbe interactions in vitro
We imaged the uptake of AF647-labeled B. fragilis by primary macrophages in vitro (Supplementary Fig. 1a) . We observed bacterial uptake and phagocytic processing as shown by costaining for early endosomal antigen 1 (EEA-1) and lysosomal-associated membrane protein 1 (LAMP-1). Although fluorescence was noted mainly in phagosomes containing bacteria (as revealed by DAPI), it was unclear whether the PSA component of AF647-labeled bacteria could detach and be captured by other cells, such as DCs. We pulsed DCs with purified PSA from GalNAz-supplemented B. fragilis and observed accumulation of labeled PSA on the surface of the DCs (Supplementary Fig. 1b ). In addition, we used time-lapse imaging to observe the dynamic uptake of labeled bacteria by macrophages in vitro ( Supplementary Fig. 1c and Supplementary Video 2) . Taken together, these data highlight the potential of MOE-BCC for studying dynamic interactions of anaerobic commensal bacteria and their surface glycans with host cells.
Dissemination of labeled bacteria in the host after peritonitis
We next characterized the immune response to AF647-labeled B. fragilis injected intraperitoneally into mice, a model of abscess formation and B. fragilis release from the intestine as documented in humans 31 . Two hours after infection, ~60% of peritoneal cells were AF647 + (Fig. 3a) in cellular composition because of labeling ( Fig. 3a-c) . We used AF647 MFI to infer the amount of labeled bacteria (or PSA) in each subset and noted that CD11b hi I-Ab + myeloid cells exhibited the highest MFI, followed by F4/80 + macrophages, neutrophils, CD11c + I-Ab + CD11b lo DCs and F4/80 − macrophages. I-Ab + CD11b lo-neg /c − cells had moderate AF647 MFI levels, and CD3e + lymphocytes had very low levels. The I-Ab + CD11b lo-neg /c − surface-expression pattern was consistent with peritoneal B cells, suggesting their involvement. We determined that this population included B-1a (CD5 + CD11b + CD43 + B220 lo ), B-1b (CD5 − CD11b + CD43 + B220 lo ) and B-2 (CD5 − CD11b − CD43 lo B220 hi ) cells, with similar AF647 MFI levels in all subsets (Fig. 3d) . We next investigated the dissemination of labeled B. fragilis (and PSA) to the spleen and draining mediastinal lymph nodes (medLNs). In the spleen, we observed an acute response to labeled B. fragilis, consisting of macrophages (SSC hi F4/80 + ), MHC class II + cells, neutrophils and CD11b + myeloid cells (Fig. 4a) . Neutrophils displayed nearly fourfold higher MFIs than any other subset. In draining medLNs, AF647 + cells were undetectable at 2 h (data not shown) but were detected in up to ~5% of medLN cells at 7 h. The highest AF647 MFI was found in CD169 + CD11b + SSC hi CD11c lo medLN macrophages, which constituted nearly half of the AF647 + population (Fig. 4b) . Of AF647 + cells in medLNs, ~20% were CD19 + B cells, which had AF647 MFIs approximately fivefold lower than those of medLN macrophages but similar to those of CD169 − CD11b + myeloid cells (Fig. 4b) . Microscopy showed AF647 accumulation in the whitepulp marginal-zone region (Fig. 4c,d ) and along the subcapsular and medullary sinuses of medLNs (Fig. 4e,f) . In both areas, fluorescence was confined to regions rich in macrophages and B cells (Fig. 4c-g ). In addition to punctate fluorescence, we observed diffuse fluorescence possibly indicative of lysed bacteria and focal release of labeled components such as PSA (Fig. 4d,g ). Although macrophage phagocytosis of bacteria was expected, the detection of fluorescence in B cells was unexpected and suggested that B cells phagocytosed or bound labeled bacteria or labeled PSA. To test this, we stained medLN sections with anti-PSA and observed PSA staining in regions with abundant AF647 + organisms (Fig. 4f) . CD169 + macrophages displayed both punctate and diffuse fluorescence, the latter colocalizing with PSA staining (Fig. 4g) . To address how B cells acquired fluorescence, we used antibodies specific for whole organisms or PSA. Whereas staining with antiserum to B. fragilis (anti-Bfrag) suggested the presence of organisms on the surface of both AF647 + macrophages and B cells, staining for PSA was markedly greater on AF647 + B cells than on macrophages (Fig. 4h) . These data suggested that AF647 fluorescence on B cells was attributable more to an association with labeled PSA than to one with whole bacteria, and that B cells are a potential cellular target of PSA after opportunistic infection by B. fragilis.
Colonization by labeled anaerobic commensal bacteria in the intestine We administered labeled B. fragilis to GF mice by gavage and analyzed the lumen of various intestinal segments by flow cytometry. We detected AF647-labeled-but not unlabeled-B. fragilis in the small intestine, with MFI only slightly reduced from input, yet well above autofluorescence (Fig. 5a) . We determined the kinetics and regional colonization of B. fragilis along the intestinal tract 2 h and 12 h after inoculation. Whereas AF647-labeled B. fragilis was detected in the small intestine, bacterial numbers in the colon were low (Fig. 5b) . By contrast, at 12 h, organisms in the colon outnumbered those in the small intestine. Indeed, at 2 h, bacterial counts were approximately 80-fold higher in the small intestine than in the colon (Fig. 5b) . At 12 h, however, B. fragilis counts were more than 40-fold higher on average in the colon than in the small intestine (Fig. 5b) . A decline in MFI at 12 h relative to that at 2 h suggested bacterial dilution of the AF647 signal, perhaps through proliferation; the increase in bacterial npg numbers in the colon was consistent with expansion ( Fig. 5b) . In addition to our experiments in GF mice, we used MOE-BCC labeling to track labeled B. fragilis in specific-pathogen-free (SPF) mice, as well as in monocolonized mice, which harbor pre-existing microflora and are perhaps a more relevant physiological model than GF mice (Fig. 5c) . In monocolonized mice, we detected labeled B. fragilis in the small intestine at 2 h and in the colon at 12 h. These findings were similar to those in SPF mice, although the amount of labeled B. fragilis in the colon at 2 h was higher in SPF mice. Whether these results are indicative of altered colonization kinetics or efficiency in the presence of pre-existing microbiota versus a single bacterial species in gnotobiotic mice requires further investigation. To further confirm this regional distribution, we examined mice monocolonized with B. fragilis from birth, using anti-PSA to determine which intestinal segment harbored B. fragilis. Consistent with our previous results, we found more B. fragilis in the colon in monocolonized mice than in the small intestine, which suggests that B. fragilis may preferentially establish a niche in the colon (Fig. 5d) .
For visual confirmation, we used intravital two-photon microscopy in live mice 32, 33 . We systematically imaged the proximal, medial and distal segments of the small intestine and visualized individual fluorescently labeled B. fragilis in the intestinal ileum ( Fig. 5e  and Supplementary Video 3) . In addition, we determined whether MOE-BCC labeling of anaerobic bacteria was compatible with noninvasive whole-body optical imaging. We gavaged mice with B. fragilis labeled with the near-infrared fluorescent dye cyanine-7 (Cy7). Using IVIS (in vivo imaging system), we detected robust fluorescence 6 h after administration in the intestinal region in live and intact GF and SPF mice ( Fig. 5f and Supplementary Video 4) . To examine the temporal-spatial distribution of labeled B. fragilis, we performed longitudinal imaging in intact mice. Fluorescence was maximal between 2 h and 9 h and progressively decreased over time, but it was still detectable at 72-96 h compared with baseline levels (Fig. 5g) . To define the spatial distribution of Cy7-labeled B. fragilis, we imaged intestinal organs excised from additional GF mice before and after administration of bacteria (Fig. 5h) . At 2 h, the fluorescent signal was strongest primarily in the stomach and in mid-and terminal regions of the small intestine, and by 6 h it had gradually decreased in intensity and become more localized to the ileum and cecum. By 12 h, fluorescence had decreased by more than fivefold along the entire intestinal tract and remained detectable in the cecum and colon.
Applicability of MOE-BCC to other gut commensals
We extended MOE-BCC labeling to 14 additional anaerobic commensals (one microaerophilic) (Fig. 6a) and one aerobic pathogen (S. aureus) (Supplementary Fig. 2) . Labeling was highly (Fig. 6a) . Some of these bacteria were better labeled with azidosugars other than GalNAz (for example, L. reuteri with ManNAz and GlcNAz). These findings suggest that other, still unidentified polysaccharide or carbohydrate moieties may be preferentially labeled in these species.
MOE-BCC labeling exposes species competition in the host intestine To determine colonization patterns and niche competition, we labeled three gut anaerobic symbionts (B. fragilis, B. ovatus and B. vulgatus) with separate fluorophores and orally administered them to GF mice (Fig. 6b) . We subdivided the small intestine and examined its proximal, medial and distal segments, as well as cecum and colon. Using flow cytometry, we detected all three species of bacteria in varying proportions throughout the intestinal tract (Fig. 6c) . B. ovatus was present throughout, whereas B. vulgatus was very limited in its colonizing capacity and was more abundant in the duodenum (segment 1 npg t e c h n i c a l r e p o r t s of the small intestine) (Fig. 6c and Supplementary Fig. 3 ). Only small clusters of fluorescently labeled B. vulgatus were visible by confocal microscopy in the lumen of the small intestine; fluorescently labeled B. fragilis and B. ovatus colonies were more abundant (Fig. 6d,e) . Although the root of this preferential localization is unknown, these data demonstrate that MOE-BCC can be a tool for studying niche preferences of gut commensals.
DISCUSSION
Gut commensals contribute to multiple physiological processes in the host, including immune system modulation 3, 34 . We used MOE-BCC to label and track anaerobic commensals and their polysaccharides in the host in real time, with no effects on viability, growth or carbohydrate metabolism. This approach was robust in labeling bacteria and delineated live, proliferating fluorescent bacteria. Despite some loss of fluorescence in bacteria over time, the shed glycans remained labeled until catabolized, presumably by host cells or in the extracellular environment, making this approach a useful tool for direct tracking of bacterial effector molecules and intact anaerobes.
Discriminating microbe from molecule permits elucidation of the roles of commensal microorganisms and their metabolites. Using MOE-BCC, we visualized real-time interactions of labeled commensal anaerobic bacteria and molecules shed from their surfaces with macrophages in vitro, as well as bacterial dissemination along the intestine in live mice. We traced the fate of B. fragilis and PSA injected into mice. Resident macrophages as well as infiltrating neutrophils and myeloid cells rapidly responded and phagocytosed labeled B. fragilis. Labeled PSA disseminated beyond the infection site: labeled B. fragilis was captured by macrophages in the splenic marginal zone and in subcapsular and medullary sinuses of medLNs. These two specialized compartments filter blood and afferent lymphatic fluid, respectively, and are pivotal in stopping the spread of infection and initiating adaptive immune responses to invading microbes 35 . The proximity of these macrophage-rich areas to B cells facilitates recognition and transfer of antigenic material 36 . In spleen and medLNs (as in the peritoneum), we found dimly fluorescent B cells that, when stained with anti-PSA, showed preferential binding of labeled PSA rather than of the whole organism. Primed B cells migrate to the T-B cell zone, where they solicit help from follicular helper T cells for immunoglobulin class switching and germinal center formation 37 ; how PSA affects this communication and the overall effect on humoral responses remain unknown. Given the ample evidence that bacterial products affect host immune responses, our approach paves the way toward providing visual proof. Besides B. fragilis, we labeled nine additional commensals and the pathogen S. aureus, demonstrating the broad applicability of this labeling method. This method can be used to label anaerobic bacteria, which constitute >99% of microbes colonizing the mammalian intestine and are incompatible with traditional labeling methods. In addition, MOE-BCC provides an alternative for organisms not amenable to genetic manipulation, or for unculturable organisms residing in the intestine.
The in vivo labeling and tracking technique described herein enables the determination of bacterial distribution and colonization preferences. We labeled three Bacteroides species with different fluorescent colors and detected and differentiated all three species throughout the intestine. It is yet unknown whether whole bacteria or only processed molecules are trafficked to lymphoid tissues and what dynamics underlie trafficking of bacteria or bacterial products to immune compartments. MOE-BCC has a vital role in addressing issues such as the role of commensals in mucosal immunology. The ability to track commensals and their immunomodulatory molecules will facilitate elucidation of the critical roles of these entities in immunologic development and disease. Metabolic labeling enables direct tracking of bacterial colonization and dissemination in animals, and it also expedites the identification of specific cells that participate in the regulation of inflammatory or immune responses that might be overlooked with other methods.
METhODS
Methods and any associated references are available in the online version of the paper.
